Results 11 to 20 of about 19,141 (206)

Prognostic Value of Atrial Phasic Dysfunction by CMR Feature Tracking for New-Onset Atrial Fibrillation in Patients with Cardiac Sarcoidosis. [PDF]

Biomedicines
Nita N, Mörike J, Felbel D, Melnic R, von Sanden F, d'Almeida S, Rottbauer W, Buckert D.   +7 more
europepmc   +3 more sources

Cardiac sarcoidosis

Heart, 2023
The diagnostic yield of endomyocardial biopsy in cardiac sarcoidosis (CS) is quite low because of the patchy involvement, and for the diagnosis of CS, existing guidelines required histological confirmation. Therefore, especially for isolated CS, diagnosis consistent with the guidelines cannot be made in a large number of patients.
Dae-Won Sohn, Jun-Bean Park
  +6 more sources

Cardiac sarcoidosis [PDF]

Journal of Internal Medicine, 2016
Clinically manifest cardiac involvement occurs in perhaps 5% of patients with sarcoidosis. The 3 principal manifestations of cardiac sarcoidosis (CS) are conduction abnormalities, ventricular arrhythmias, and heart failure. An estimated 20% to 25% of patients with pulmonary/systemic sarcoidosis have asymptomatic cardiac involvement (clinically silent ...
Lehtonen J., Kupari M., Kandolin R., Lehtonen J., Kupari M., Kandolin R.   +5 more
  +7 more sources

Underdiagnosis of cardiac sarcoidosis by ECG and echocardiography in cases of extracardiac sarcoidosis

ERJ Open Research, 2022
Background Although screening with 12-lead electrocardiography and transthoracic echocardiography for cardiac involvement has been recommended for patients with biopsy-proven extracardiac sarcoidosis, cardiac sarcoidosis has been reported even in ...
Hiroshi Ohira, Takahiro Sato, Osamu Manabe, Noriko Oyama-Manabe, Akiko Hayashishita, Toshitaka Nakaya, Junichi Nakamura, Naoko Suzuki, Ayako Sugimoto, Sho Furuya, Satonori Tsuneta, Taku Watanabe, Ichizo Tsujino, Satoshi Konno   +13 more
doaj   +1 more source

Comparative effectiveness of disease-modifying antirheumatic drugs for patients with cardiac sarcoidosis. [PDF]

Rheumatology (Oxford)
Brooks L, Kivlin W, Mohananey D, Sabchyshyn V, Putman M.   +4 more
europepmc   +3 more sources

Isolated Cardiac Sarcoidosis Masquerading as Peripheral Vertigo: A Case Report [PDF]

Cureus
Boppe S, Surkunda S, Stanley W, Ballal A.   +3 more
europepmc   +3 more sources

Indirect pathological indicators for cardiac sarcoidosis on endomyocardial biopsy [PDF]

Journal of Pathology and Translational Medicine, 2020
Background The definitive pathologic diagnosis of cardiac sarcoidosis requires observation of a granuloma in the myocardial tissue. It is common, however, to receive a “negative” report for a clinically probable case. We would like to advise pathologists
Myung-Jin Cha, Jeong-Wook Seo, Seil Oh, Eun-Ah Park, Sang-Han Lee, Moon Young Kim, Jae-Young Park   +6 more
doaj   +1 more source

Challenges of cardiac sarcoidosis

Frontiers in Medicine, 2023
Sarcoidosis is a multisystem granulomatosis of unknown origin, which can involve almost any organ. Most frequently the disease involves the lungs and mediastinal lymph nodes, but it can affect the skin, the eyes, nervous system, the heart, kidneys ...
Irina R. Strambu, Irina R. Strambu
doaj   +1 more source

Cardiac Sarcoidosis

The Thoracic and Cardiovascular Surgeon, 2009
Sarcoidosis is a systemic disease which affects many organs, including the heart. Cardiac sarcoidosis has a reported incidence of about 25 % and carries a poor prognosis. It can occur in the form of conduction abnormalities, pericardial and valvular heart disease, congestive heart failure, arrhythmias and sudden cardiac death.
Mitropoulos, F.A., Floudas, C.S., Kanakis, M.A., Vaiopoulos, G.A.   +3 more
openaire   +5 more sources

Features and clinical impact of extra-cardiac lesions with 18F-fluorodeoxyglucose positron emission tomography in patients with suspected cardiac sarcoidosis

International Journal of Cardiology: Heart & Vasculature, 2020
Background: Sarcoidosis is a systemic inflammatory disorder and can often affect any other organs beyond the heart. Whole-body 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is used to detect not only cardiac but also extra-cardiac ...
Haruhiko Higashi, Shinji Inaba, Chiharuko Iio, Katsuji Inoue, Akiyoshi Ogimoto, Masao Miyagawa, Teruhito Mochizuki, Shuntaro Ikeda, Osamu Yamaguchi   +8 more
doaj   +1 more source